Trademark: 97821393
Word
ALVYMRO
Status
Registered
Status Code
700
Status Date
Tuesday, March 26, 2024
Serial Number
97821393
Registration Number
7338265
Registration Date
Tuesday, March 26, 2024
Mark Type
4000
Filing Date
Friday, March 3, 2023
Published for Opposition
Tuesday, January 9, 2024

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Mar 26, 2024
Notice Of Registration Confirmation Emailed
Mar 26, 2024
Registered-Principal Register
Jan 9, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 9, 2024
Published For Opposition
Dec 20, 2023
Notification Of Notice Of Publication E-Mailed
Dec 5, 2023
Approved For Pub - Principal Register
Nov 29, 2023
Assigned To Examiner
Jun 27, 2023
Teas Change Of Correspondence Received
Jun 27, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 27, 2023
Teas Change Of Owner Address Received
Mar 22, 2023
New Application Office Supplied Data Entered
Mar 7, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24